Instruments and reagents for blood analysis

Boule Diagnostics

Boule Diagnostics is a Swedish diagnostics company that develops, manufactures and markets instruments and consumable products for blood diagnostics, specializing in blood cell counting (CBC) systems, in both human and veterinary hematology. Boule Diagnostics is a global company with approximately 170 employees located in Sweden, USA and Mexico and with a market presence via distributors in addition to its own sales and marketing organisation in more than 100 countries.

Financials

BOULE DIAGNOSTICS

SEKm 2017 2018 2019
Sales 428 434 480
Sales growth (%) 7,8 1,5 10,7
EBITDA 65 76 89
EBITDA margin (%) 15,3 17,5 18,6
EBIT adj 54 67 79
EBIT adj margin (%) 12,7 15,4 16,4
Pretax profit 53 67 78
EPS rep 1,94 2,59 3
EPS growth (%) 1,5 33,1 16,1
EPS adj 1,94 2,59 3
DPS 0,5 1 1
EV/EBITDA (x) 17,7 14,2 11,9
EV/EBIT adj (x) 21,3 16,1 13,5
P/E (x) 33,7 23,1 19,9
P/E adj (x) 33,7 23,1 19,9
EV/sales (x) 2,7 2,5 2,2
FCF yield (%) 3,5 -1,7 2,9
Dividend yield (%) 0,8 1,7 1,7
Net IB debt/EBITDA -1,7 -1,5 -1,4

Main shareholders

Boule Diagnostics

Main shareholders Share capital % Voting shares % Verified
Martin Gren (Grenspecialisten) 10.7 % 10.7 % 30 Sep 2018
Svolder 10.0 % 10.0 % 30 Sep 2018
SEB Fonder 7.7 % 9.7 % 30 Sep 2018
Thomas Eklund 9.3 % 9.3 % 30 Sep 2018
Swedbank Robur Fonder 9.2 % 9.2 % 30 Sep 2018
Tredje AP-fonden 6.3 % 6.3 % 30 Sep 2018
Handelsbanken Fonder 6.0 % 6.0 % 30 Sep 2018
Länsförsäkringar Fonder 4.4 % 4.4 % 30 Sep 2018
Norges Bank 2.4 % 2.4 % 30 Sep 2018
Lannebo Fonder 2.1 % 2.1 % 30 Sep 2018

Insider list

Boule Diagnostics

Name
Gustaf Peter Reinhold von Ehrenheim
Claes Blanche
Claes Blanche
Fredrik Ekdahl
Christina Rubenhag
Christina Rubenhag
Hans Johansson
Claes Blanche
Fredrik Dalborg
Fredrik Alpsten
Show More